Leigh Zawel

Insider Reports History

Entity
Individual
Location
C/O Cullinan Management, Inc., One Main Street Suite 520, Cambridge, MA
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leigh Zawel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. Chief Scientific Officer, Small Molecules Common Stock 69.8K $870K $12.46 Feb 11, 2022 Direct
Cullinan Oncology, Inc. Chief Scientific Officer, Small Molecules Stock Option (Right to Buy) 65K Feb 11, 2022 Direct

Insider Reports Filed by Leigh Zawel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Feb 11, 2022 2 $0 4 Feb 15, 2022 Chief Scientific Officer, Small Molecules
CGEM Cullinan Oncology, Inc. Oct 15, 2021 1 -$489K 4 Oct 18, 2021 Chief Scientific Officer, Small Molecules
CGEM Cullinan Oncology, Inc. Oct 7, 2021 1 -$27K 4 Oct 12, 2021 Chief Scientific Officer, Small Molecules
CGEM Cullinan Oncology, Inc. Sep 20, 2021 1 -$188K 4 Sep 21, 2021 Chief Scientific Officer, Small Molecules
CGEM Cullinan Oncology, Inc. Sep 7, 2021 1 -$814K 4 Sep 8, 2021 Chief Scientific Officer, Small Molecules
CGEM Cullinan Oncology, Inc. Aug 23, 2021 1 -$815K 4/A Aug 26, 2021 Officer
CGEM Cullinan Oncology, Inc. Aug 9, 2021 5 -$753K 4/A Aug 26, 2021 Officer